Skip to main content
Premium Trial:

Request an Annual Quote

Healthlinx Inks Distribution Deal to Offer Ovarian Cancer Diagnostic Test in India

NEW YORK (GenomeWeb News) – Australian biomarker-based diagnostic firm Healthlinx today announced a distribution deal to begin offering its OvPlex test in India in the third quarter.

The deal between Healthlinx and distribution partners Inex Innovations Exchange and Metropolis Healthcare will make OvPlex, an ovarian cancer diagnostic test, available initially in Mumbai beginning Aug. 1, with expansion into other major Indian cities in the months to follow.

The launch of OvPlex into India follows "excellent market acceptance and growth in Singapore and Malaysia," where the test has been available since late 2010, Healthlinx said, adding that it and Inex are investigating the possibility of getting the test reimbursed by private insurers in India.

OvPlex is a five-biomarker panel that was originally launched in Australia in 2008. Healthlinx has started a second larger study for the test, aiming to prove a diagnostic accuracy of more than 97 percent for early-stage ovarian cancer, the company said. The study will be based on 1,150 new samples and includes two new biomarkers, AGR2 and HTX010.

Inex, based in Singapore, develops and distributes medical devices and diagnostics. Indian firm Metropolis has 85 diagnostic centers and collection centers in India, Sri Lanka, South Africa, and the Middle East.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.